跳至主要内容
临床试验/NCT01465542
NCT01465542已完成不适用

Treatment of Acetaminophen Toxicity With Intravenous vs. Oral N-acetylcysteine: A Retrospective Review

Akron Children's Hospital1 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2011年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
1
主要终点
Length of NAC treatment in hours

研究概览

简要总结

Retrospective chart review of patients who receive N-acetylcysteine for Acetaminophen(APAP) toxicity to assess length of oral vs. IV treatment and the effect of a Clinical Pharmacology and Toxicology division in the management of APAP ingestions.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
1 Month 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Admitted to CHMCA between June 1, 2008 to June 30, 2011
  • Qualifying ICD-9 diagnosis code for the following APAP overdose situations: poisoning, accidental, suicide attempt, therapeutic use, assault, and undetermined (965.4, E850.4, E950.0, E935.4, E962.0, E980.0)
  • Serum APAP concentration above the possible hepatotoxic line on the Rumack-Matthew's nomogram if obtained > 4 hours post ingestion
  • Between ages 0-21 years on date of admission
  • Acute APAP ingestion

排除标准

  • Serum APAP concentrations not actually documented
  • Did not receive the oral or IV NAC treatment
  • Preexisting liver disease such as cirrhosis or hepatitis C
  • Patient > 21 years of age on the date of admission
  • Chronic APAP ingestion

结局指标

主要结局

Length of NAC treatment in hours

时间窗: Retrospective data collection for patient's hospital admission, max estimated 5days

Length of NAC treatment (in hours) for both IV and PO formulations used in patients with APAP toxicity

次要结局

  • Pharmacology & Toxicology consults(Retrospective data collection for length of patient's hospital admission, max estimated 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Martha Blackford, PharmD

PharmD

Akron Children's Hospital

研究点 (1)

Loading locations...

相似试验